Advertisement

Loading...

Aeterna Zentaris Inc.

AEZS.TOTSX
Healthcare
Biotechnology
$8.29
$0.62(8.08%)
Canadian Market is Open • 13:52

Aeterna Zentaris Inc. Fundamental Analysis

Aeterna Zentaris Inc. (AEZS.TO) shows weak financial fundamentals with a PE ratio of -8.14, profit margin of -78.93%, and ROE of -13.16%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position84.50%
PEG Ratio-0.11
Current Ratio8.01

Areas of Concern

ROE-13.16%
Operating Margin-4.00%
We analyze AEZS.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -61.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-61.9/100

We analyze AEZS.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

AEZS.TO struggles to generate sufficient returns from assets.

ROA > 10%
-9.59%

Valuation Score

Excellent

AEZS.TO trades at attractive valuation levels.

PE < 25
-8.14
PEG Ratio < 2
-0.11

Growth Score

Weak

AEZS.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AEZS.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.19
Current Ratio > 1
8.01

Profitability Score

Weak

AEZS.TO struggles to sustain strong margins.

ROE > 15%
-1315.63%
Net Margin ≥ 15%
-78.93%
Positive Free Cash Flow
No

Key Financial Metrics

Is AEZS.TO Expensive or Cheap?

P/E Ratio

AEZS.TO trades at -8.14 times earnings. This suggests potential undervaluation.

-8.14

PEG Ratio

When adjusting for growth, AEZS.TO's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values Aeterna Zentaris Inc. at 1.59 times its book value. This may indicate undervaluation.

1.59

EV/EBITDA

Enterprise value stands at -2.71 times EBITDA. This is generally considered low.

-2.71

How Well Does AEZS.TO Make Money?

Net Profit Margin

For every $100 in sales, Aeterna Zentaris Inc. keeps $-78.93 as profit after all expenses.

-78.93%

Operating Margin

Core operations generate -4.00 in profit for every $100 in revenue, before interest and taxes.

-4.00%

ROE

Management delivers $-13.16 in profit for every $100 of shareholder equity.

-13.16%

ROA

Aeterna Zentaris Inc. generates $-9.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.59%

Following the Money - Real Cash Generation

Operating Cash Flow

Aeterna Zentaris Inc. generates limited operating cash flow of $-10.79M, signaling weaker underlying cash strength.

$-10.79M

Free Cash Flow

Aeterna Zentaris Inc. generates weak or negative free cash flow of $-10.81M, restricting financial flexibility.

$-10.81M

FCF Per Share

Each share generates $-3.53 in free cash annually.

$-3.53

FCF Yield

AEZS.TO converts -94.01% of its market value into free cash.

-94.01%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.05

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.19

vs 25 benchmark

Current Ratio

Current assets to current liabilities

8.01

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.13

vs 25 benchmark

ROA

Return on assets percentage

-0.10

vs 25 benchmark

ROCE

Return on capital employed

-0.55

vs 25 benchmark

How AEZS.TO Stacks Against Its Sector Peers

MetricAEZS.TO ValueSector AveragePerformance
P/E Ratio-8.1427.91 Better (Cheaper)
ROE-13.16%687.00% Weak
Net Margin-78.93%-45285.00% (disorted) Weak
Debt/Equity0.190.33 Strong (Low Leverage)
Current Ratio8.012795.76 Strong Liquidity
ROA-9.59%-13557.00% (disorted) Weak

AEZS.TO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aeterna Zentaris Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ